cystic fibrosis

Glutathione Articles - Cystic Fibrosis

Korytina GF; Iaibaeva DG; Viktorova TV., Polymorphism of glutathione-S-transferase M1 and P1 genes in patients with cystic fibrosis and chronic respiratory tract diseases. Genetika. 2004 Mar; 40(3):401-8.
Lands, L; Grey V; Smountas A; Kramer V; McKenna D, Lymphocyte Glutathione Levels in Children With Cystic Fibrosis. Chest. 1999; 116:201-205.
Bufi PL, Cystic fibrosis: Therapeutic options for co-management. Alternative Medicine Review. 1997; 2(2):104-115.
Wood LG, Fitzgerald DA, Lee AK, Garg ML, Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 2003;77:150–9.
Bishop C, Hudson VM, Hilton SC, Wilde C, A Pilot Study of the Effect of Inhaled Buffered Reduced Glutathione on the Clinical Status of Patients With Cystic Fibrosis. Chest 2005;127;308-317.
Hudson VM, New Insights Into the Pathogenesis of Cystic Fibrosis: Pivotal Role of Glutathione System Dysfunction and Implications for Therapy. Treat Respir Med 2004; 3 (6):353-363.
Childers M, Eckel G, Himmel A, Caldwell J, A new model of cystic fibrosis pathology: Lack of transport of glutathione and its thiocyanate conjugates. Medical Hypotheses, Vol 68, Issue 1:101-112.
Visca A, Bishop CT, Hilton SC, Hudson VM, Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled observational study. J Cyst Fibros. 2008 May 20; Epub ahead of print.
Ntimbane T, Comte B, Mailhot G, Berthiaume Y, Poitout V, Prentki M, Rabasa-Lhoret R, Levy E, Cystic Fibrosis-Related Diabetes: From CFTR Dysfunction to Oxidative Stress. Clin Biochem Rev Vol 30, November 2008;I 153

If you would like us to send you abstracts of any of the articles listed above (or full text PDF's when available), please contact us by phone or e-mail:

Caron Lassiter

Toll Free:
Tel: 800-227-2627
Fax: 800-369-0302

Local:
Tel: 205-879-6551
Fax: 205-871-2568

Email:
classiter@wellnesshealth.com